COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common, ...

A new study looked at the long-term prognosis of French people who were hospitalised between 2020 and 2022 for heart ...

A study today in JAMA suggests that hospitalized patients—primarily previously healthy young men—have considerably fewer cardiovascular sequelae by 18 months if they develop myocarditis after COVID-19 ...

Even with a low rates of cardiovascular adverse events in patients treated with immune checkpoint inhibitors, cancer care ...

Purpose: The treatment options for viral myocarditis caused by coxsackievirus B are summarized. Summary: Myocarditis is a common cause of dilated cardiomyopathy. The most common causes of ...

Myocarditis is the inflammation of the heart muscle—also known as the myocardium. Symptoms of myocarditis vary widely, depending on the extent and severity of inflammation that you're experiencing and ...

Myocarditis associated with ICI therapy is rare but poses a high risk of death, according to data from 2 systematic reviews.

Patients with post-COVID-19 mRNA vaccination myocarditis show a lower frequency of cardiovascular complications than those with conventional myocarditis or post-COVID-19 myocarditis at 18 months.

Patients with post-COVID-19 mRNA vaccination myocarditis show a lower frequency of cardiovascular complications than those with conventional myocarditis or post-COVID-19 myocarditis at 18 months ...

The fly in the ointment was a case of myocarditis – inflammation of the heart muscle – that was seen in an 11-year-old boy enrolled in Study 9001-103 and was deemed to be serious. Treatment ...